Northwestern University researchers have identified structural features in engineered cell receptors that correlate with ...

The Hong Kong company saw a reduction in body weight across both cohorts with no serious adverse events reported.

Weight-inclusive health care is the provision of equitable care without perpetuating weight stigma among patients of all body ...

Spire Wealth Management bought a new stake in Structure Therapeutics Inc. (NASDAQ:GPCR – Free Report) in the 4th quarter, Holdings Channel.com reports. The fund bought 8,949 shares of the company’s ...

Eggs used to be one of the cheapest protein sources out there. Back when they cost $2 a dozen, the 84 grams of protein in a carton of extra-large eggs worked out to just 48 cents per 20 grams of ...

For the purpose of this visual protein guide, we looked at what 100 grams of protein looks like across different dietary styles -- vegan, vegetarian, omnivorous and carnivore. Four eggs (24 grams ...

The NHS had been facing supply issues with glucagon-like peptide receptor agonists (GLP-1 RAs, or GLP-1 analogues), a range of drugs used for managing blood glucose levels in people with type 2 ...

Based on one hypothesis, proglucagon may contain a sorting signal within its structure ... to active GLP-1 in alpha cells is very inefficient. Also in this study, analysis of secreted ...

The Nedd4 WW domain–ENaC βP2 peptide structure expands our understanding of the mechanisms involved in WW domain–ligand recognition and the molecular basis of Liddle syndrome. Figure 1 ...

Medications known as glucagon-like peptide 1 (GLP-1) receptor agonists are taking over the healthcare industry. While you may not be familiar with the term "GLP-1," I'd wager you'll recognize some ...

Background: Despite their potential, Glucagon-like peptide-1 receptor agonists (GLP-1 RA) have not been well studied in cardiac amyloidosis (CA) as randomized trials on GLP-1 RA have excluded patients ...